Alpine Immune Sciences Inc (NASDAQ:ALPN)

8.49
Delayed Data
As of 12:01pm ET
 +0.36 / +4.43%
Today’s Change
6.85
Today|||52-Week Range
12.87
-24.20%
Year-to-Date
No recent news for Alpine Immune Sciences Inc.

Today’s Trading

Previous close8.13
Today’s open8.25
Day’s range8.11 - 8.49
Volume18,298
Average volume (3 months)18,959
Market cap$112.6M
Data as of 12:01pm ET, 07/23/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-52.50%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio5.1
Price/Sales41.94
Price/Book1.42

Competitors

 Today’s
change
Today’s
% change
NVIVInVivo Therapeutics ...-0.06-2.66%
CLBSCaladrius Bioscience...+0.06+1.10%
MTEMMolecular Templates ...+0.15+3.00%
CSBRChampions Oncology I...+0.04+0.46%
Data as of 12:02pm ET, 07/23/2018

Financials

Next reporting dateJuly 31, 2018
EPS forecast (this quarter)-$0.43
Annual revenue (last year)$1.7M
Annual profit (last year)-$7.8M
Net profit margin-449.62%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Executive Officer
Mitchell H. Gold
President &
Director
Jay Venkatesan
Corporate headquarters
Seattle, Washington

Forecasts